Bannach-Brown Alexandra, Rackoll Torsten, Macleod Malcolm R, McCann Sarah K
QUEST Center for Responsible Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Centre for Clinical Brain Sciences, The University of Edinburgh Medical School, Edinburgh, UK.
BMC Med Res Methodol. 2025 Mar 10;25(1):66. doi: 10.1186/s12874-025-02524-2.
In this review article, we provide a comprehensive overview of current practices and challenges associated with research synthesis in preclinical biomedical research. We identify critical barriers and roadblocks that impede effective identification, utilisation, and integration of research findings to inform decision making in research translation. We examine practices at each stage of the research lifecycle, including study design, conduct, and publishing, that can be optimised to facilitate the conduct of timely, accurate, and comprehensive evidence synthesis. These practices are anchored in open science and engaging with the broader research community to ensure evidence is accessible and useful to all stakeholders. We underscore the need for collective action from researchers, synthesis specialists, institutions, publishers and journals, funders, infrastructure providers, and policymakers, who all play a key role in fostering an open, robust and synthesis-ready research environment, for an accelerated trajectory towards integrated biomedical research and translation.
在这篇综述文章中,我们全面概述了临床前生物医学研究中与研究综合相关的当前实践和挑战。我们确定了阻碍有效识别、利用和整合研究结果以指导研究转化决策的关键障碍和阻碍。我们审视了研究生命周期各个阶段(包括研究设计、实施和发表)的实践,这些实践可以进行优化,以促进及时、准确和全面的证据综合。这些实践以开放科学为基础,并与更广泛的研究界互动,以确保证据对所有利益相关者都是可获取且有用的。我们强调研究人员、综合专家、机构、出版商和期刊、资助者、基础设施提供者以及政策制定者需要采取集体行动,他们在营造一个开放、强大且适合综合研究的环境中都发挥着关键作用,以加速迈向综合生物医学研究与转化的进程。